ArticleEuropean journal of translational myology2025
Retraction: Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary.
Article in European journal of translational myology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retraction: Rafiee B, Karbalay-Doust S, Tabei SMB, Azarpira N, Alaee S, Lohrasbi P, Bahmanpour S. Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary. Eur J Transl Myol 2022; 32(2):10409. DOI: 10.4081/ejtm.2022.10409 The article has been retracted by the authors, in agreement with the Editor-in-Chief, Professor Ugo Carraro, and the Publisher, following an investigation into Figure 6 (specifically panels a and c). Although the image in question was not intentionally manipulated to mislead, and the error stemmed from an inadvertent mistake during figure preparation, the authors fully recognize the seriousness of the issue and the importance of maintaining the highest standards of scientific integrity. The authors apologize for this oversight and for any inconvenience it may have caused to the editorial board, reviewers, and readers, and are committed to learning from this experience and reinforcing stricter internal review processes to prevent such issues in future publications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.